C07D233/02

Lipid particle, composition comprising lipid particle, and method for delivering activators to cell

The present embodiment provides a compound represented by the formula (1):
Q-CHR.sub.2(1)
(Q is a nitrogen-containing aliphatic group containing two or more tertiary nitrogens but no oxygen, and R is an aliphatic group containing a biodegradable group). From the compound in combination with other lipids such as a lipid capable of reducing aggregation, lipid particles can be formed. Further, the compound can be used for a pharmaceutical composition to deliver an activator into cells.

Epoxy curing agents, compositions and uses thereof

The present invention relates to epoxy curing agents which are obtained from the reaction of a polyalkylene polyether modified polyepoxide resin and a polyamine component. They polyamine component is a reaction product of a polyethylene polyamine having 3 to 10 nitrogen atoms, for example, diethylenetriamine (DETA), and at least one aldehyde having 1 to 8 carbon atoms, for example, formaldehyde. The epoxy curing agent may be used as part of a two component coating system in the curing of liquid or pre-dispersed curable epoxy resins.

Epoxy curing agents, compositions and uses thereof

The present invention relates to epoxy curing agents which are obtained from the reaction of a polyalkylene polyether modified polyepoxide resin and a polyamine component. They polyamine component is a reaction product of a polyethylene polyamine having 3 to 10 nitrogen atoms, for example, diethylenetriamine (DETA), and at least one aldehyde having 1 to 8 carbon atoms, for example, formaldehyde. The epoxy curing agent may be used as part of a two component coating system in the curing of liquid or pre-dispersed curable epoxy resins.

METHOD FOR PRODUCING TRIARYLORGANOBORATES

The invention relates to a process for preparing triaryl organoborates proceeding from organoboronic esters in the presence of an n-valent cation 1/n K.sup.n+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.

Solid paraffin inhibitor and corrosion inhibitor compositions

The present disclosure describes solid compositions comprising a paraffin inhibitor and a corrosion inhibitor. The paraffin inhibitors include polymers having various repeat units containing one or more ester moieties. The corrosion inhibitors can be imidazoline compounds, quaternary ammonium compounds, or a combination thereof. These solid compositions can be used to treat subterranean hydrocarbon-containing reservoir and can inhibit or reduce paraffin deposition in the reservoir and/or inhibit or reduce corrosion in a piece of equipment in contact with the reservoir.

Solid paraffin inhibitor and corrosion inhibitor compositions

The present disclosure describes solid compositions comprising a paraffin inhibitor and a corrosion inhibitor. The paraffin inhibitors include polymers having various repeat units containing one or more ester moieties. The corrosion inhibitors can be imidazoline compounds, quaternary ammonium compounds, or a combination thereof. These solid compositions can be used to treat subterranean hydrocarbon-containing reservoir and can inhibit or reduce paraffin deposition in the reservoir and/or inhibit or reduce corrosion in a piece of equipment in contact with the reservoir.

STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME

The present disclosure relates in part to sterically hindered N-aliphatic N-heterocyclic carbene (NHC) ligands, which are readily synthetically available from inexpensive starting materials. The present disclosure further relates to NHC catalyst complexes comprising transition metals such as Cu, Ag, Au, and Pd. Furthermore, the present disclosure provides methods for using the catalysts described herein in a number of organic transformations, including alkyne hydroboration and hydration, in addition to CO, CC, and CN coupling reactions.

4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound

An 4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid compound, its synthesis, and its use as an antimicrobial agent.

COMPOSITION COMPRISING HETEROCYCLIC COMPOUND AND 4,4'-METHYLENE DIPHENYL DIISOCYANATE

This disclosure relates to a composition comprising (a) 4,4-methylene diphenyl diisocyanate (4,4-MDI), and (b) at least one heterocyclic compound comprising as ring moiety at least one structure of formula (I) as defined in the description. The heterocyclic compound can suppress the formation of 4,4-MDI dimer and thus prevent the formation of insoluble solids and extend the shelf life of 4,4-MDI.

COMPOSITION COMPRISING HETEROCYCLIC COMPOUND AND 4,4'-METHYLENE DIPHENYL DIISOCYANATE

This disclosure relates to a composition comprising (a) 4,4-methylene diphenyl diisocyanate (4,4-MDI), and (b) at least one heterocyclic compound comprising as ring moiety at least one structure of formula (I) as defined in the description. The heterocyclic compound can suppress the formation of 4,4-MDI dimer and thus prevent the formation of insoluble solids and extend the shelf life of 4,4-MDI.